Relapsing Herpes Zoster after Sputnik V Vaccination: Periodontitis, Conjunctivitis and Neuralgia

Hans-Bernd B and Jargin SV

Published on: 2025-11-17

Abstract

The vaccine quality is important because of the risk of side effects. Political pressures for rapid approval of vaccines are potentially conductive to the distribution of preparations having suboptimal and/or unstable quality. A case of 69-years-old male with relapsing herpes zoster after the Gam-COVID-Vac (Sputnik V) vaccination is presented here, followed by an overview of potential adverse effects. The rarity of reports on the side effects of COVID-19 vaccinations may be caused by policies discouraging such reporting. The information about association of symptoms with vaccination sometimes remains unrecorded. In conclusion, the premature approval of vaccines without long-term safety data should be avoided. The natural process of ageing is associated with a reduction in cellular immunity, which may predispose to infections. Aged people sometimes pay for victories in the vaccine race and other rivalries.